Join the Exciting Scientific Showcase: Uncovering Jaguar Health’s Revolutionary Crofelemer for Rare Disease Treatment – Hosted by Ladenburg Thalmann on December 18, 2024!
Description:
Crofelemer is the subject of five clinical efforts – three proof-of-concept investigator-initiated trials (IIT) and two Phase 2 studies – for the rare disease indications of microvillus inclusion disease (MVID) and/or short bowel syndrome with intestinal failure (SBS-IF) in the US, EU, and/or Middle East/North Africa regions; availability of IIT proof-of-concept results potentially in Q2 2025. Virtual event 11:00 AM to 12:00 PM Eastern Registration open now for financial and business community; Massimo Radaelli, PhD, CEO of the rare disease-focused Jaguar family company Napo Therapeutics and President of Jaguar International, named ‘Best CEO BioPharmaceuticals of the Year’. SAN FRANCISCO, CA / ACCESSWIRE / December 13, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) today announced that Ladenburg Thalmann is hosting a Scientific Showcase webinar on Wednesday, December 18, 2024 from 11:00 a.m. to 12:00 p.m.
How This Will Affect Me:
As an individual, the revolutionary treatment showcased in the event could potentially offer hope for those suffering from rare diseases like microvillus inclusion disease and short bowel syndrome with intestinal failure. The advancements in the medical field can bring about new treatment options and improve the quality of life for patients facing these challenging conditions.
How This Will Affect the World:
The unveiling of Jaguar Health’s Crofelemer treatment for rare diseases has the potential to make a significant impact on the global healthcare landscape. By introducing innovative therapies for conditions that currently have limited treatment options, it can pave the way for future developments in treating rare diseases and improving overall public health.
Conclusion:
Join us on December 18, 2024, for Ladenburg Thalmann’s Scientific Showcase event to learn more about the groundbreaking Crofelemer treatment developed by Jaguar Health. Together, we can support the advancement of rare disease treatments and make a positive difference in the world of healthcare.
